G2610133Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Dacomitinib (PF299804, PF299) - ≥99% , Receptor protein-tyrosine kinase erbB-4 inhibitor, CAS No.1110813-31-4, Receptor protein-tyrosine kinase erbB-4 inhibitor
Disponibile su ordine
QUALITÀ & PUREZZA ≥99%
Synonyms
PF299804|PF299|dacomitinibum|(2E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-PIPERIDIN-1-YLBUT-2-ENAMIDE|(E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide|Dacomitinib anhydrous|Dacomitinib (PF-00299804)|PF-299804|(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide|Dacomitinib [USAN:INN]|Dacomitinib (INN)|2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-, (2E)-|Dacomitinib (PF299804, PF299)|DACOMITINIB [WHO-DD]|Dacomitinib|(2E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide|(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide|(E)-N-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide|Dacomitinib (PF299804)|PF-299804 (Dacomitinib PF-00299804)|(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide|Dacomitinib (PF299804, PF-00299804)|DACOMITINIB [INN]|(E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide|PF-00299804
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads